|Articles|December 2, 2021

Pharmaceutical Technology

  • Pharmaceutical Technology, December 2021 Issue
  • Volume 45
  • Issue 12

Using Tolerance Intervals to Assess Conformance to Requirements

The authors introduce the idea of asymmetrical tolerance intervals as an aid in fully assessing product performance relative to product or process requirements.

Unused, misused, or misunderstood, statistical tolerance intervals are fundamentally different from statistical confidence intervals, which provide interval estimates for summary statistics, such as mean and standard deviation. Tolerance intervals were developed as a tool to provide confidence intervals for a population proportion. With insights gained, the tolerance interval can be effectively used to develop product and process specifications as well as determine conformance to requirements.

Statistical tolerance intervals are routinely used to assess a product’s conformance to requirements and to provide a range within which one can expect product attributes to be contained. In this paper, the authors focus on parametric tolerance intervals that assume normally distributed data. The authors introduce the idea of asymmetrical tolerance intervals as an aid in fully assessing product performance relative to product or process requirements.Tolerance intervals are generated by collecting data through sampling of representative product and processes and using tolerance interval factors (k) to create the tolerance limits. Tolerance interval factors are widely available in tables and available in many statistical computer programs.

Click here for a PDF of the article.

About the authors

Lynn D. Torbeck is a statistician with Torbeck and Associates. Chuck Pheatt is Professor Emeritus with Emporia State University.

Article Details

Pharmaceutical Technology
Volume 45, Number 12
December 2021
Page: 38–42

Citation

When referring to this article, please cite it as L. D. Torbeck and C. Pheatt, “Using Tolerance Intervals to Assess Conformance to Requirements,” Pharmaceutical Technology 45 (12) 2021.


Related to this article

Intravenous therapy; drip chamber in focus against a colorful background | Image Credit: ©Anna Jurkovska -stock.adobe.com
This article explores the historical use of silicone oil in the performance of primary drug product packaging; design of experiment test results for selection of the cleaning agent and CCPs; assessment of visible residue limits and Fourier-transform infrared spectroscopy surface analysis; and setting health-based exposure limits for silicone oil using a non-uniform distribution model, and a previously published permitted daily exposure.
Quality inspector walking through processing area with stainless tanks and tablet | Image Credit: ©Surachai -stock.adobe.com
At the PDA/FDA Joint Regulatory Conference 2026, Helen Motamen, MS global head, Sanofi Quality Audit, Inspection, Intelligence & Advocacy, at Sanofi, provided advice for creating a strong internal audit program.